Stockscreener 앱 받기
8.54
0.58%
-0.05
시간 외 거래:
8.54
전일 마감가:
$8.59
열려 있는:
$8.54
하루 거래량:
465.38K
Relative Volume:
0.84
시가총액:
$459.73M
수익:
$9.68M
순이익/손실:
$-244.09M
주가수익비율:
-1.8833
EPS:
-4.5346
순현금흐름:
$-168.85M
1주 성능:
-8.27%
1개월 성능:
-5.43%
6개월 성능:
+5.82%
1년 성능:
-33.70%
1일 변동 폭
$8.3775
$8.63
1주일 범위
$8.3775
$9.54
52주 변동 폭
$4.32
$13.71
Prothena Corporation Plc Stock (PRTA) Company Profile
명칭
Prothena Corporation Plc
전화
011-353-1-236-2500
주소
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Compare PRTA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
8.54 | 462.43M | 9.68M | -244.09M | -168.85M | -4.5346 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-28 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2025-05-27 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-05-27 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-05-27 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-12-20 | 개시 | Chardan Capital Markets | Buy |
| 2024-01-30 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-04-24 | 개시 | SVB Securities | Outperform |
| 2023-01-27 | 개시 | Piper Sandler | Overweight |
| 2022-11-04 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-11-19 | 개시 | JMP Securities | Mkt Outperform |
| 2021-06-18 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-06-08 | 재확인 | Oppenheimer | Outperform |
| 2021-05-26 | 개시 | Citigroup | Buy |
| 2021-02-26 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-02-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-12-07 | 개시 | H.C. Wainwright | Buy |
| 2020-07-09 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2019-11-19 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-05-21 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2018-04-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2018-04-05 | 재확인 | Barclays | Overweight |
| 2017-11-20 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2017-09-29 | 재확인 | BTIG Research | Buy |
| 2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-11 | 개시 | Jefferies | Buy |
| 2017-04-12 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-04-12 | 개시 | Piper Jaffray | Overweight |
| 2017-03-02 | 개시 | Instinet | Buy |
| 2016-12-21 | 개시 | SunTrust | Buy |
| 2016-11-03 | 개시 | Deutsche Bank | Buy |
| 2016-08-04 | 재확인 | Barclays | Overweight |
| 2016-05-13 | 개시 | Barclays | Overweight |
| 2016-02-19 | 재확인 | Wedbush | Outperform |
| 2016-01-21 | 개시 | Credit Suisse | Outperform |
모두보기
Prothena Corporation Plc 주식(PRTA)의 최신 뉴스
Prothena Q4 earnings meet estimates, pipeline progress in focus - MSN
Prothena authorizes up to $100 million share repurchase plan - MSN
Earnings Update: Will Prothena Corporation plc outperform its industry peers2026 Major Catalysts & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
History Review: Is Prothena Corporation plc attractive for institutional investors2026 Volume Leaders & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Prothena Corp plc Stock (ISIN: IE00B91XRN20) Faces Biotech Headwinds Amid Pipeline Delays - AD HOC NEWS
Prothena Corp plc Stock (ISIN: IE00B91XRN20) Faces Headwinds Amid Biotech Volatility - AD HOC NEWS
Prothena Corporation plc $PRTA Stake Lessened by Prosight Management LP - MarketBeat
Prothena Corp plc Stock (ISIN: IE00B91XRN20) Under Pressure Amid Biotech Volatility - AD HOC NEWS
Prothena Corp plc Stock (ISIN: IE00B91XRN20) Faces Pressure Amid Biotech Volatility - AD HOC NEWS
Citizens reaffirms Prothena stock rating on Novo Nordisk milestone By Investing.com - Investing.com UK
Prothena earns $50M milestone from Novo Nordisk for drug trial - Investing.com Nigeria
IPO Launch: Will Prothena Corporation plc outperform tech stocks2026 Movers & Weekly High Return Forecasts - baoquankhu1.vn
Prothena (NASDAQ:PRTA) Share Price Passes Above 50-Day Moving AverageTime to Sell? - MarketBeat
Discipline and Rules-Based Execution in PRTA Response - Stock Traders Daily
Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related t - PharmiWeb.com
Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy - The Joplin Globe
Prothena Corporation Plc Receives $50 Million Clinical Milestone Payment From Novo Nordisk - marketscreener.com
PRTA Earnings History & Surprises | EPS & Revenue Results | PROTHENA CORP PLC (NASDAQ:PRTA) - ChartMill
Is Prothena Corporation plc stock a dividend growth opportunity2025 Buyback Activity & Real-Time Buy Zone Alerts - Naître et grandir
Aug Reactions: Is Prothena Corporation plc attractive for institutional investors - baoquankhu1.vn
Prothena: A Hold With 2 Late-Stage Programs Underway But With Caution (NASDAQ:PRTA) - Seeking Alpha
Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade - Finviz
Prothena (NASDAQ:PRTA) Shares Up 8.7%Still a Buy? - MarketBeat
Prothena Corporation plc (NASDAQ:PRTA) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Prothena Corporation plc (NASDAQ:PRTA) Given Average Recommendation of “Hold” by Analysts - Defense World
PRTA SEC FilingsProthena 10-K, 10-Q, 8-K Forms - Stock Titan
Prothena Announces $100 Million Share Repurchase Program - The Globe and Mail
Prothena Corporation plc (PRTA) Stock Analysis: Navigating a 137% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Prothena authorizes $100 million share buyback program - Investing.com South Africa
Prothena Corporation plc announces an Equity Buyback for $100 million worth of its shares. - marketscreener.com
Prothena (NASDAQ: PRTA) okays $100M share buyback through 2026 - Stock Titan
Prothena Approves $100 Million Share Buyback Authorization - marketscreener.com
Prothena stock jumps on $100M share buyback authorization By Investing.com - Investing.com UK
Prothena Corporation plc (NASDAQ: PRTA) clears shelf to sell up to $200M in shares - Stock Titan
Prothena Announces up to $100 Million Share Repurchase Plan - The Joplin Globe
PROTHENA CORP PUBLIC LTD CO SEC 10-K Report - TradingView
Prothena (NASDAQ: PRTA) reshapes pipeline and cuts staff in 10-K - Stock Titan
Prothena Corporation plc authorizes a Buyback Plan. - marketscreener.com
Behavioral Patterns of PRTA and Institutional Flows - Stock Traders Daily
FY2026 EPS Estimates for Prothena Boosted by HC Wainwright - MarketBeat
Royal Bank Of Canada Increases Prothena (NASDAQ:PRTA) Price Target to $12.00 - Defense World
RBC Capital Raises Price Target for Prothena Corp (PRTA) to $12. - GuruFocus
Prothena Q4 Earnings Meet Estimates, Pipeline Progress in Focus - Finviz
Prothena (NASDAQ:PRTA) Price Target Raised to $12.00 - MarketBeat
Prothena Corporation plc (NASDAQ:PRTA) Q4 2025 Earnings Call Transcript - Insider Monkey
Prothena Corporation plc Q4 2025 Earnings Call Summary - Yahoo Finance
Prothena Corp PLC (PRTA) Q4 2025 Earnings Call Highlights: Strat - GuruFocus
Prothena Q4 Earnings Call Highlights - MarketBeat
Can Prothena Corporation plc be recession proofTrade Exit Summary & Growth Focused Stock Reports - mfd.ru
Prothena (PRTA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Prothena (PRTA) Projects Financial Outlook and Clinical Milestones - GuruFocus
Prothena Corporation Plc (PRTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Prothena Corporation Plc 주식 (PRTA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 10% Owner |
May 06 '25 |
Sale |
7.64 |
1,984,053 |
15,164,712 |
5,304,596 |
| EcoR1 Capital, LLC | 10% Owner |
May 05 '25 |
Sale |
8.11 |
977,693 |
7,930,166 |
7,288,649 |
1.20%
0.06%
자본화:
|
볼륨(24시간):